Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT02918097 Completed - Bipolar Disorder Clinical Trials

Cost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive Episode

Start date: May 2010
Phase: Phase 4
Study type: Interventional

To evaluate the effectiveness of an algorithm for Bipolar Disorder depressive episodes (BDD) using medications available in the Brazilian Public Healthcare System (SUS). Quality of life assessment of these patients was also employed. A randomized pragmatic trial was conducted. An algorithm was developed for the treatment of episodes of bipolar disorder depression episodes.

NCT ID: NCT02911285 Completed - Clinical trials for Alcohol Use Disorder (AUD)

NAC for Treating Comorbid PTSD and SUD

DoD-NAC
Start date: October 2016
Phase: Phase 2
Study type: Interventional

As a result of sustained operations in Afghanistan and Iraq, there are an increasing number of U.S. military Veterans with substance use disorders and comorbid posttraumatic stress disorder (PTSD). If left untreated, individuals with substance use disorders and PTSD are at increased risk for developing other mental health problems (e.g., depression, anxiety), suicidal ideation and attempts, medical problems, reduced resiliency and military readiness, vocational problems, and family/social impairment. This study will determine the benefits of N-acetylcysteine (NAC) in treating alcohol use disorder and comorbid post-traumatic stress disorder (PTSD) among military Veterans.

NCT ID: NCT02911194 Completed - Clinical trials for Autism Spectrum Disorder

a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD)

A2MT
Start date: September 2016
Phase: N/A
Study type: Interventional

Under double-blind, placebo-controlled, cross-over conditions, the short-term effects of use of A1 beta casein free milk (a2 milk) and milk containing A1 beta casein will be compared in a sample of pre-pubescent boys diagnosed with an autism spectrum disorder (ASD) with concurrent features of attention-deficit hyperactivity disorder (ADHD).

NCT ID: NCT02911155 Completed - Breast Cancer Clinical Trials

Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists

Start date: September 21, 2016
Phase:
Study type: Observational

Background: The field of nuclear medicine has changed a lot in the past decades. Technology has gotten better, so patients are exposed to less radiation. But now workers are doing procedures more often and using lead aprons less. So they may be exposed to more radiation. This may put them at higher risk for cancers and other health problems that are related to radiation. Researchers want to collect data from technologists to learn more about the risks and appropriate doses of radiation. Objective: To learn more about the risks and appropriate doses of radiation for nuclear medicine technologists. Eligibility: Adults who were first certified in nuclear medicine technology in the United States after 1980. They must be living in the United States. They must not be participants in the USRT study. Design: Participants will be recruited online. Participants will complete an online survey. It will take about a half hour. This will have questions about their work with nuclear medicine procedures. There will be questions about the kinds of procedures and how often they do them. Participants will give a short work history. This will include the names of current and past employers. Participants will allow researchers to get records of their film badge dose readings. These will come from dosimetry providers. Dosimetry data will not be shared with participants. Researchers can t ensure the how accurate or complete the data are.

NCT ID: NCT02910921 Completed - Migraine Disorders Clinical Trials

Individualized Prediction of Migraine Attacks Using a Mobile Phone App and Fitbit

Migraine Alert
Start date: November 2016
Phase:
Study type: Observational

This trial is collaboration between Mayo Clinic, Second Opinion Health (Simon Bloch, simon@somobilehealth.com 408-981-3814) and Allergan. Mayo Clinic investigators are conducting the clinical trial, Second Opinion Health is providing the software for use in the trial (Migraine Alert app for data collection, analysis and machine learning algorithms), and Allergan is providing funding. The investigators hypothesize that the use of a mobile phone app and Fitbit wearable to collect daily headache diary data, exposure/trigger data and physiologic data will predict the occurrence of migraine attacks with high accuracy. The objective of the trial is to assess the ability to use daily exposure/trigger and symptom data, as well as physiologic data (collected by Fitbit) to create individual predictive migraine models to accurately predict migraine attacks in individual patients via a mobile phone app.

NCT ID: NCT02909959 Completed - Clinical trials for Autism Spectrum Disorder

Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder

Start date: March 1, 2017
Phase: Phase 2
Study type: Interventional

The aim of this randomized controlled trial is to determine if a nutritional supplement containing broccoli sprout and seed extracts, a rich source of sulforaphane, is effective in reducing core symptoms of autism spectrum disorder (ASD). The study will also explore the safety and tolerability of a sulforaphane supplement in young men with ASD, as well as its effects on challenging neuropsychiatric symptoms that are commonly associated with ASD, such as hyperactivity, irritability, and repetitive movements.

NCT ID: NCT02909491 Completed - Geriatric Disorders Clinical Trials

Ionized Calcium and Behavioural Disorders in Older Adults (CALICO Study)

Start date: June 2016
Phase: N/A
Study type: Observational

The primary objective of this study is to determine whether geriatric inpatients with severe behavioral disorders exhibit higher serum ionized calcium concentration than geriatric inpatients without behavioral disorders, but no difference in serum calcium or corrected calcium concentrations. The secondary objective of this study is to determine whether the serum ionized calcium concentration is associated with behavioral and cognitive performance among geriatric inpatients.

NCT ID: NCT02904980 Completed - Clinical trials for Developmental Coordination Disorder

The Effects of a Group-based Gaze Training Intervention for Children With Developmental Coordination Disorder

Start date: February 2015
Phase: N/A
Study type: Interventional

The aim of this study was to integrate a gaze training intervention (i.e., quiet eye training; QET) that has been shown to improve the throwing and catching skill of children with Developmental Coordination Disorder (DCD), within an approach (i.e., group therapy) that might alleviate the psychosocial influence of these motor skill deficits.

NCT ID: NCT02902952 Completed - Control Condition Clinical Trials

Physical Exercise to Reduce Anxiety in Underserved Children With ASD

PETRA
Start date: October 2016
Phase: N/A
Study type: Interventional

Anxiety is one of the most frequent comorbidities in children with ASD leading to poor clinical outcomes. Physical exercise has been shown to be a promising and easy to implement intervention for reducing anxiety. However, little is known about the feasibility and efficacy of physical exercise to reduce anxiety in children with ASD from underserved, low-income families. Children with ASD, ages 6 - 12 years old from low-income and Latino families will be recruited for the study and assigned to an exercise intervention group and a sedentary control group. The physical exercise program is an eight-week program, administered three times per week in small groups. Compliance, parent-rated anxiety, and salivary cortisol will be measured before and after completion of the exercise and control group interventions.

NCT ID: NCT02901587 Completed - Schizophrenia Clinical Trials

Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder

Start date: September 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate the effect of Lu AF35700 on electrical activity in the heart as measured on an electrocardiogram (ECG) in patients with schizophrenia or schizoaffective disorder after 6 weeks of treatment